Michelle Monje

2025 Brain Prize awarded for uncovering how tumours hijack neural activity

Two neuroscientists have been awarded the prestigious Brain Prize 2025 for their groundbreaking discoveries showing how neural activity in the brain can promote cancer development, opening new avenues for glioma treatment.

IHF Awards 2025

IHF Awards 2025: International healthcare institutions invited to showcase innovations across seven categories

The International Hospital Federation (IHF) has launched its 2025 Awards programme, with a call for international healthcare institutions to enter. Submissions are open until 2 May. This year’s awards mark a decade of celebrating excellence in healthcare leadership and innovation. The 2025 Awards recognise outstanding achievements across seven categories, with winners to be announced at […]

Fraunhofer to unveil practical AI and robotics solutions for digital healthcare

Eight Fraunhofer institutes will jointly showcase their latest innovations in digital healthcare at DMEA 2025 in Berlin from April 8-10, focusing on practical solutions that integrate seamlessly into existing healthcare workflows. The exhibition will highlight advancements in trustworthy AI, robotic assistance systems, and secure health data spaces designed to address real-world challenges in the medical […]

Yourgene Genomic Services Laboratory

Yourgene launches expanded non-invasive prenatal testing service

Yourgene Health has introduced IONA Care+, an enhanced non-invasive prenatal testing (NIPT) service that expands screening capabilities to include microdeletion syndromes alongside chromosomal abnormalities, offering expectant parents comprehensive genetic risk assessment from as early as 10 weeks’ gestation.

Vitestro unveils Aletta, the first autonomous blood collection robot

Vitestro, a Netherlands-based medical robotics company, has launched Aletta™, the world’s first Autonomous Robotic Phlebotomy Device™ (ARPD™). This CE-marked technology utilises AI-powered Doppler ultrasound imaging to identify veins and employs robotic-controlled needle insertion for blood collection, promising enhanced precision and consistency compared to traditional manual methods.

Vetter Pharma has unveiled its V-OVS next syringe closure system

Vetter advances syringe closure technology with next-generation system

Vetter Pharma has unveiled its V-OVS® next syringe closure system, evolving their proprietary technology based on real-world clinical feedback. The updated design promises enhanced functionality, improved handling, and intuitive opening mechanisms while maintaining stringent product integrity standards for sterile injectables.

Varian HyperSight imaging solution

Varian receives FDA clearance for enhanced imaging technology across radiotherapy systems

Varian, a Siemens Healthineers company, has received FDA 510(k) clearance for its HyperSight imaging solution on TrueBeam and Edge radiotherapy systems. This technology enables high-quality adaptive radiotherapy planning with reduced imaging times and improved anatomical accuracy, potentially enhancing treatment precision and patient comfort.

Culicoides paraensis - biting midge that can cuase Oropouche infection

Oropouche virus: warning as threat spreads beyond the Amazon

As global health authorities tackle with a host of established infectious disease threats, a previously obscure virus is steadily expanding its reach beyond its traditional Amazonian stronghold. Oropouche virus, first identified in Trinidad and Tobago in 1955, has emerged as a significant public health concern across South America and the Caribbean, with recent outbreaks reported […]

Siemens Healthineers introduces flexible imaging software solution

Siemens Healthineers has unveiled Syngo Flexinity, a novel approach to medical imaging software access designed for healthcare institutions. The system offers scalable, on-demand access to the company’s complete imaging software portfolio, allowing healthcare providers to adapt to changing clinical demands without predicting exact software requirements or locations.

Perfuuze Zipline Access Catheters

Perfuze secures FDA clearance for stroke treatment catheters and €22M funding

Irish medical device company Perfuze has achieved two significant milestones in advancing acute ischemic stroke treatment technology. The firm has received FDA 510(k) clearance for its Zipline™ Access Catheters alongside securing €22 million in follow-on funding to support commercial rollout and ongoing research initiatives.